Mini Review
Accepted on 26 Jul 2024
Sacituzumab Govitecan in Triple-Negative Breast Cancer: from bench to bedside, and back
in Cancer Immunity and Immunotherapy
Mini Review
Accepted on 26 Jul 2024
in Cancer Immunity and Immunotherapy
Clinical Trial
Accepted on 26 Jul 2024
in Healthy Longevity
Original Research
Accepted on 26 Jul 2024
in Veterinary Experimental and Diagnostic Pathology
Editorial
Accepted on 26 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 26 Jul 2024
in Antibiotic Resistance and New Antimicrobial drugs
Opinion
Accepted on 26 Jul 2024
in Abdominal Transplantation
Original Research
Accepted on 26 Jul 2024
in Reproduction
Original Research
Accepted on 26 Jul 2024
in Health Economics
Original Research
Accepted on 26 Jul 2024
in Antibiotic Resistance
Correction
Accepted on 26 Jul 2024
in Blockchain Technologies
Original Research
Accepted on 26 Jul 2024
in Inflammation
Original Research
Accepted on 26 Jul 2024
in Translational Medicine
Original Research
Accepted on 26 Jul 2024
in Healthcare Professions Education
Original Research
Accepted on 26 Jul 2024
in Pharmacogenetics and Pharmacogenomics
Original Research
Accepted on 26 Jul 2024
in Anesthesiology and Animal Pain Management
Review
Accepted on 26 Jul 2024
in Molecular Innate Immunity